
The second phase of this global collaborative platform includes initial roll-out of a federated trust framework for secure enterprise-wide identity management and single sign-on access to multiple end-user applications.

The second phase of this global collaborative platform includes initial roll-out of a federated trust framework for secure enterprise-wide identity management and single sign-on access to multiple end-user applications.



Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.

The alliance will offer hybrid studies that combine existing data from electronic health records (EHRs) and medical claims (from Optum) with global, site-based clinical research (Parexel).



The Veeva TMF Maturity Model is available as a self-service online tool or as a more detailed, in-person evaluation with a subject matter expert.

The solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan.


The acquisition adds Clinverse’s automated financial management technology solutions to Bioclinica’s portfolio of solutions.

When paying and reimbursing clinical research volunteers for study participation, what can be done to make the experience more patient centric?

Telling signs from U.S., Russia, Latin America and UK indicate that governments are squeezing as much value as possible out of their spending on pills and procedures.

Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.


Private laboratory Biotrial was testing a pain and mood disorder medication for Portuguese pharma company Bial on humans for the first time, in a Phase I trial.

As in other needs in the clinical trials chain, endpoint adjudication is an area that can be greatly improved by technology.

The latest people and business news includes ACRO appointments and awards for CROs and service providers.


Amgen, Celgene, Independence Blue Cross, Bank of America and many more collaborate to deliver immunotherapies more quickly to cancer patients through historic drug development alliance.

BSI, with a long history of publishing multi-industry standards, intends to help develop and implement standards of excellence for clinical research sites.




Move helps biosimulation consulting support for clients in China, as well as support China's expansion of its fast-track drug approval process.

New Phase I clinical in Miami offers gateway location to Latin America.


The Rater Station℠ platform has been used extensively in Central Nervous System clinical trials, and version 4.0 is currently being used in two clinical trials that are actively recruiting.
